1. Differentiated thyroid cancer
Conditions
Interventions
Satisfactory outcome group:None
Unsatisfied group:None
Sponsors
The First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with DTC combined with Hashimoto's thyroiditis (or chronic lymphocytic thyroiditis) confirmed by postoperative pathology. 2. Patients who stopped taking euthyroid and low-iodine diet for 2-4 weeks before the first 1311 treatment, and whose serum TSH level was > 30uIU/ml; 3. Regular follow-up and complete data were obtained after surgery and 1311.
Exclusion criteria
Exclusion criteria: 1.Incomplete clinical and pathological data or lack of regular follow-up; 2.Has a history of other malignant tumors; 3.Those with DTC combined with other special pathological types such as undifferentiated thyroid cancer or medullary thyroid cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Single Photon Emission Computed Tomography (SPECT);Thyroglobulin and related antibodies;Ultrasonography of the thyroid gland; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thyroid function;Blood routine test, blood biochemistry test; | — |
Countries
China
Contacts
Public ContactZeng Lingpeng
The First Affiliated Hospital of Nanchang University
Outcome results
None listed